EISAI CO.,LTD
Corporate VCTokyo · Seed–Growth · 1 people tracked
Investment thesis
Eisai is a global pharmaceutical company operating under its human health care (hhc) Concept, focused on developing solutions in neurology and oncology and reducing health disparities, including work to eliminate neglected tropical diseases.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's websiteFrequently asked questions
- What stage does EISAI CO.,LTD invest at?
- EISAI CO.,LTD invests at the Seed, Series A, Growth stages.
- What sectors does EISAI CO.,LTD focus on?
- EISAI CO.,LTD focuses on Biotech, Healthtech, Sector Agnostic.
- Where is EISAI CO.,LTD located?
- EISAI CO.,LTD is headquartered in Tokyo, JP.
Images
Similar investors
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
Granatus Ventures is a venture capital firm that backs startups worldwide leveraging Armenia's potential as an emerging technology hub.
Lux Capital is a venture capital firm that backs companies working to turn science fiction into reality, focusing on emerging science and technology.
Menlo Ventures is a venture capital firm that backs transformative, early-stage technology companies reshaping how people live and work.
Norwest is a venture and growth equity investment firm that has backed over 700 companies across sectors including AI, retail, and healthcare, working alongside entrepreneurs from early to late-stage growth.